EASL's International Liver CongressTM Virtual Press Office
The International Liver Congress™ 2014 will take place in London (United Kingdom) April 9 - 13, 2014 at the ExCel London Exhibition and Convention Centre. This newsroom is designed to keep you up-to-date on all EASL Press Office Activities.
Gut microbiota may play a role in the development of alcoholic liver disease
New Chinese herbal medicine has significant potential in treating Hepatitis C
New data showing efficacy of simeprevir- and sofosbuvir-based regimens in HCV genotype 4-infected patients
New interferon-free, all-oral 3D regimen achieves high SVR in chronic HCV genotype 1 patients
Low vitamin D linked to fatty liver disease in UK children
New advances in hepatocellular carcinoma diagnosis, staging and treatment all predicted to improve patient outcomes
Three new studies help clarify optimal use of combination therapy in chronic hepatitis B patients
Obeticholic acid produces meaningful biochemical and clinical improvements in PBC cirrhosis patients
Immunotherapy could help tackle tough Liver Cancers
Press registration guidelines
Press & Media Information
International Liver CongressTM 2014 abstracts will be posted on the congress website as follows:
- Monday 24 March 2014 at 10:00 CET - a large quantity of abstracts showing abstract title, author names and abstract data will be posted online two weeks ahead of the congress. These abstracts are publicly available and NOT under embargo.
- A smaller quantity of abstracts will be retained and presented during the official EASL Press Office activities and/or in official EASL Press Office materials. These abstracts are under embargo until 6:00 BST on the day the abstract is presented at the congress. Embargoed abstract titles, author and institute names will be made available on the congress website on Monday March 24, however, the related data will only be released at 6:00 BST on the day of the abstract pres...